Sagimet Biosciences Inc. (SGMT) › Cash & EquivalentsSagimet Biosciences Inc. (SGMT) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2022-12-31: $158.0K2023-12-31: $75.14M2024-12-31: $75.84M2025-12-31: $35.02M$35.02M2022-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$35.02M-53.8%2026-03-11Balance as of period end2024-12-31$75.84M+0.9%2026-03-11Balance as of period end2023-12-31$75.14M+47456.3%2025-03-12Balance as of period end2022-12-31$158.0K—2024-03-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)